Top 3 Marijuana Penny Stocks Under $2: 2024 Watchlist

2024’s Hidden Gems: Cannabis Stocks Trading Under $2

In the rapidly evolving world of cannabis investments, ancillary marijuana stocks present a unique opportunity for investors looking beyond the conventional market. These stocks, which represent companies providing support services and products to the cannabis industry without directly handling the plant, are gaining traction as the industry matures. Analysts predict significant growth in the global cannabis market, with projections indicating a surge from $20.5 billion in 2020 to an astounding $90.4 billion by 2026, marking a compound annual growth rate (CAGR) of around 28%. This exponential growth is attributed not only to the increasing legalization of cannabis across various regions but also to the diversification of its applications in medical, recreational, and industrial sectors.

For investors seeking short-term gains in the cannabis sector, Canadian cannabis stocks offer a viable option, given the country’s early move to legalize marijuana for both medical and recreational use. Trading these stocks, however, requires a nuanced approach. Experts recommend employing technical analysis to identify market trends and potential entry and exit points, thus maximizing profit potential. Additionally, considering the volatile nature of this market, proper risk management strategies are imperative. Investors are advised to set clear stop-loss orders and only invest funds they can afford to lose, thereby mitigating the risks associated with the often unpredictable swings in cannabis stock prices. The combination of a strategic approach and cautious risk management can turn the dynamic cannabis market into a rewarding venture for astute traders.

[Read More] Cannabis Investing Today: 3 Top Marijuana Stocks For Your Watchlist

Top Cannabis Stocks You Can Buy for Under $2 in 2024

  1. Greenlane Holdings, Inc. (NASDAQ: GNLN)
  2. High Tide Inc. (NASDAQ: HITI)
  3. Aurora Cannabis Inc. (NASDAQ: ACB)

Greenlane Holdings, Inc.

Greenlane Holdings, Inc. is a prominent player in the cannabis industry. It specializes in the distribution of premium cannabis accessories. The company also offers a diverse range of compliance packaging and vaporization products. Founded in 2005, Greenlane has established itself as a key supplier for dispensaries and smoke shops.


Greenlane operated numerous physical stores across the United States. They had a particularly strong presence in states where cannabis is legal. This includes states like California, Colorado, and Oregon. These states are known for their progressive cannabis policies. Greenlane’s extensive network enables it to reach a wide customer base. This includes both recreational and medicinal users. They cater to a diverse range of cannabis-related needs.

Q2 2023 Highlights

Greenlane Holdings, Inc. faced a challenging Q2 in 2023, as indicated by its financial results. The company’s revenue saw a decline, falling to $19.6 million from $24.0 million in Q1 2023. This decrease reflects a significant shift in the company’s financial dynamics within a quarter. Despite this downturn in revenue, Greenlane managed to reduce its operating expenses. They lowered these expenses by $0.9 million, a 6.2% decrease compared to Q1 2023. This reduction signifies the company’s efforts to streamline operations amidst financial pressures.

However, Greenlane’s net loss widened slightly in Q2 2023, reaching $10.5 million compared to $10.2 million in the previous quarter. This resulted in a basic and diluted net loss of $6.56 per share, up from $6.40 per share in Q1 2023. On a more positive note, the adjusted EBITDA loss improved, decreasing to $5.8 million from a loss of $6.8 million in Q1 2023. Amid these financial challenges, Greenlane continued to innovate, launching 21 new products in the year. These include the ORAFLEX line, the Groove product range, and the critically acclaimed ARTIQ vaporizer by DaVinci. This push for innovation showcases Greenlane’s commitment to growth and adaptation in a dynamic market.

GNLN Stock Performance

GNLN stock closed at $0.5301 on December 14th, down 1.80% in the past month of trading. Currently, the stock has a 52-week price range of $0.48-$5.84 and is down 81.56% year to date.

[Read More] 3 Canadian Marijuana Stocks To Watch Today

High Tide Inc.

High Tide Inc. is a key player in the cannabis retail sector. It specializes in cannabis retail stores and e-commerce platforms. The company also focuses on manufacturing and distributing cannabis lifestyle products. Founded in 2009, High Tide has become a recognized name in the cannabis industry.

HITI Stock

As of my last update in April 2023, High Tide operated a significant number of retail locations. Their presence is strong, particularly in Canada. In the United States, they have been expanding steadily. Key states with a notable High Tide presence include Illinois and Pennsylvania. These states have burgeoning cannabis markets. High Tide’s growth strategy focuses on expanding its retail footprint. They also aim to enhance their online presence. This approach caters to a diverse customer base in North America.

Third Fiscal Quarter 2023 – Financial Highlights

High Tide Inc. demonstrated remarkable financial performance in its third fiscal quarter of 2023. The company’s revenue soared to $124.4 million, marking a significant 30% increase year-over-year and a 5% rise sequentially from the previous quarter. This growth underscores High Tide’s expanding market presence and operational efficiency. Additionally, the company’s shift towards profitability was evident in its free cash flow, which turned positive at $4.1 million, a notable improvement from the negative $2.0 million in the previous quarter. This turnaround was largely attributed to the company’s effective cost-control measures and the success of its discount club model, which contributed to a sharp rise in same-store sales growth.

The company’s gross profit also saw a substantial increase, reaching $34.6 million, up 34% from the same period in 2022 and 10% from the previous quarter. This consistent gross profit margin of 28% reflects High Tide’s ability to maintain profitability amidst growth. The adjusted EBITDA showed an impressive surge to $10.2 million, including a one-time return from Manitoba’s SRF, indicating a 140% increase year-over-year and a 55% sequential rise. These figures are a testament to High Tide’s strategic initiatives, including cost-saving measures that led to a reduction in general and administrative expenses to 5.2% of revenue.

The company also benefited from operational efficiencies, including the integration of the Fastendr technology in its stores, which helped lower salary, wages, and benefits costs to 11.1% of revenue. Furthermore, sales from its Cabanalytics business data platform climbed to $6.5 million, up 19% year-over-year. The company’s ELITE cannabis loyalty program also saw rapid growth, reaching over 18,800 members. Despite these positive developments, the company reported a net loss of $3.6 million, influenced by a decrease in income from the revaluation of derivative liabilities. However, the overall financial health of High Tide Inc. seems robust, with cash on hand totaling $25.7 million, a 40% increase from the previous year.

HITI Stock Performance

The shares of HITI finished at $1.62 on December 14th, up 25.58% in the last month of trading. The stock is trading in a 52-week price range of $1.0340 to $2.30, up 7.28% year to date.

[Read More] Best Cannabis Stocks With Triple-Digit Gains Year-To-Date

Aurora Cannabis Inc.

Aurora Cannabis Inc. is a Canadian company that is at the cutting edge of the global cannabis market. The company is a well-known brand that specializes in cannabis products for both medical and recreational usage. Dried cannabis, oil derivatives, and, most recently, cutting-edge edibles and vapes are among their product offerings. With a varied product portfolio that meets a broad range of customer preferences and medical needs, Aurora stands out in a crowded industry.


Aurora Cannabis operates numerous stores across Canada, where it holds a strong market presence. The company has strategically located its stores in provinces with high demand for cannabis products. Notably, Aurora has a significant presence in Alberta and Ontario, which are key markets in the Canadian cannabis landscape. While the company primarily operates in Canada, it also explores international opportunities. This global outlook is evident in its ventures into European and Latin American markets. Aurora’s expansion strategy is carefully aligned with evolving legal frameworks and market dynamics, positioning it as a global leader in the cannabis industry.

Fiscal 2024 Second Quarter Highlights

Aurora Cannabis achieved a record positive adjusted EBITDA of $3.4 million. This marks a significant financial milestone for the company. Their quarterly net revenue saw a 30% year-over-year increase, reaching $63.4 million. This growth is largely attributed to a 42% rise in global medical cannabis sales.

The company also reported a strong net cash position, exceeding $200 million. They expect to fully repay the remaining US$5.3 million balance of their convertible senior notes by February 2024. Furthermore, Aurora Cannabis re-affirms its goal of achieving positive free cash flow in the 2024 calendar year. This objective underscores their financial stability and growth trajectory.

ACB Stock Performance

ACB stock closed at $0.4893 on December 14th, up 4.91% in the last month of trading. Currently, the stock has a 52-week price range of $0.41-$1.2050, down 46.97% year to date.

[Read More] High Potential: Unveiling the Most Promising Marijuana Penny Stocks of the Moment

Investing In The Top Marijuana Penny Stocks Before 2024

In conclusion, the landscape of cannabis stocks, particularly those like ancillary and Canadian cannabis stocks, presents a dynamic and rapidly evolving investment opportunity. The impressive projected growth of the global cannabis industry, forecasted to expand significantly by 2026, underlines the potential these markets hold. Ancillary cannabis stocks offer a unique angle, allowing investors to tap into the burgeoning industry without direct involvement in cannabis production. Meanwhile, Canadian cannabis stocks, benefiting from early legalization and a mature market, provide a different avenue for investment. Both sectors demand strategic trading approaches, incorporating technical analysis and stringent risk management to navigate their inherent volatility.

For investors considering these markets, the key lies in balancing potential rewards with the risks. Short-term trading of marijuana stocks requires a nuanced understanding of market trends and the discipline to adhere to well-planned risk management strategies. As the global cannabis industry continues to grow and diversify, these stocks offer a compelling blend of opportunity and challenge. Investors who are well-informed and cautious, yet bold in their strategies, may find these markets particularly rewarding. The future of cannabis investments, driven by evolving regulations, consumer trends, and technological advancements, is poised to offer intriguing possibilities for those willing to engage with these dynamic sectors.

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like